文献速递细菌感染、耐药与抗菌药物

大流行多重耐药大肠埃希菌ST131的肠道定植特征

Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131.
PubMed 文献 · J Infect Dis · 2018-01-01

本研究评估多重耐药大肠埃希菌ST131在人肠上皮细胞和小鼠肠道定植模型中的定植特征。ST131菌株较益生菌和共生菌更易黏附并侵入人肠上皮细胞;参考菌株EC958在小鼠肠道建立持续定植,1型菌毛表达介导更高定植水平,细菌载量以小鼠肠道远端最高且未引起明显病理。EC958可结合黏液及下方人肠上皮。

要点

  • ST131菌株黏附并侵入人肠上皮细胞的能力强于益生菌和共生菌。
  • 参考菌株EC958在小鼠肠道建立持续定植,1型菌毛表达介导更高定植水平。
  • 小鼠肠道细菌载量以远端最高且未引起明显病理,EC958可结合黏液及下方人肠上皮。

核心结论

  • ST131菌株能有效定植哺乳动物肠道并长期持续存在。
  • 1型菌毛增强ST131肠道定植,提示甘露糖苷类(目前作为膀胱感染和克罗恩病治疗药物开发)也可能用于限制肠道ST131储库。

研究设计与样本

  • 评估临床ST131分离株及1型菌毛缺失突变体对人肠上皮的定植,并采用小鼠肠道定植模型。
  • 对小鼠肠道组织进行组织学分析以评估病理和ST131定位。
  • 关键发现于产黏液人细胞系和肠道活检标本中加以验证。

主要发现

  • ST131菌株黏附并侵入人肠上皮细胞的程度高于益生菌和共生菌。
  • 参考ST131菌株EC958在小鼠中建立持续肠道定植,1型菌毛表达介导更高的定植水平。
  • 细菌载量在小鼠肠道远端最高,且未引起任何明显病理。
  • EC958可结合黏液及下方人肠上皮。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidemiological studies point to the gut as a key reservoir of multidrug resistant Escherichia coli multilocus sequence type 131 (ST131), a globally dominant pathogenic clone causing urinary tract and bloodstream infections. Here we report a detailed investigation of its intestinal lifestyle. METHODS: Clinical ST131 isolates and type 1 fimbriae null mutants were assessed for colonization of human intestinal epithelia and in mouse intestinal colonization models. Mouse gut tissue underwent histologic analysis for pathology and ST131 localization. Key findings were corroborated in mucus-producing human cell lines and intestinal biopsy specimens. RESULTS: ST131 strains adhered to and invaded human intestinal epithelial cells more than probiotic and commensal strains. The reference ST131 strain EC958 established persistent intestinal colonization in mice, and expression of type 1 fimbriae mediated higher colonization levels. Bacterial loads were highest in the distal parts of the mouse intestine and did not cause any obvious pathology. Further analysis revealed that EC958 could bind to both mucus and underlying human intestinal epithelia. CONCLUSIONS: ST131 strains can efficiently colonize the mammalian gut and persist long term. Type 1 fimbriae enhance ST131 intestinal colonization, suggesting that mannosides, currently developed as therapeutics for bladder infections and Crohn's disease, could also be used to limit intestinal ST131 reservoirs.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sarkar S, Hutton ML, Vagenas D, et al. Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131. J Infect Dis. 2018. PMID: 29471349. doi:10.1093/infdis/jiy031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。